Brief: Immunovia Q1 Revenue SEK 139 Thousand
14/05/2025 07:30
May 14 (Reuters) - Immunovia Q1 adjusted EPS SEK -0.24. Q1 adjusted free cash flow SEK -24.4 million Q1 net income SEK -57.8 million
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study